Inflammx Therapeutics Inc
1 clinical trials · Sponsor
◉ Watch Inflammx Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| Study of Xiflamâ„¢ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC) (NCT06437223) | Inflammx Therapeutics Inc | 2024-03-12 |
Track Inflammx Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.